1. Home
  2. TITN vs REPL Comparison

TITN vs REPL Comparison

Compare TITN & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Titan Machinery Inc.

TITN

Titan Machinery Inc.

HOLD

Current Price

$18.35

Market Cap

443.9M

ML Signal

HOLD

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

HOLD

Current Price

$11.45

Market Cap

407.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TITN
REPL
Founded
1980
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
443.9M
407.1M
IPO Year
2007
2018

Fundamental Metrics

Financial Performance
Metric
TITN
REPL
Price
$18.35
$11.45
Analyst Decision
Hold
Hold
Analyst Count
3
9
Target Price
$19.00
$5.67
AVG Volume (30 Days)
248.6K
3.8M
Earning Date
05-21-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,427,107,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.75
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.21
$1.50
52 Week High
$25.00
$13.24

Technical Indicators

Market Signals
Indicator
TITN
REPL
Relative Strength Index (RSI) 37.97 70.22
Support Level $15.32 $6.81
Resistance Level $20.47 N/A
Average True Range (ATR) 0.98 0.92
MACD -0.18 -0.05
Stochastic Oscillator 3.98 73.98

Price Performance

Historical Comparison
TITN
REPL

About TITN Titan Machinery Inc.

Titan Machinery Inc owns and operates a network of full-service agricultural and construction equipment stores. The company sells and repairs agricultural equipment, including machinery and attachments for large-scale farming and home and gardening purposes, as well as construction equipment. It operates through following segments: The Agriculture segment sells, services, and rents machinery and related parts and attachments, for uses ranging from large-scale farming to home and garden use, The construction segment sells, services, and rents machinery, and related parts and attachments, for uses ranging from heavy construction to light industrial machinery use, and the Europe and Australia segments.

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

Share on Social Networks: